The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era
CONCLUSIONS: Despite a near-doubling of take-home methadone doses during the COVID-19 exemption period, the increase in take-home doses was not associated with negative treatment outcomes in methadone-adherent clients.PMID:34670453 | DOI:10.1080/00952990.2021.1979991
Source: The American Journal of Drug and Alcohol Abuse - Category: Addiction Authors: Ofer Amram Solmaz Amiri Victoria Panwala Robert Lutz Paul J Joudrey Eugenia Socias Source Type: research
More News: Addiction | Alcoholism | COVID-19 | Emergency Medicine | Men | Methadone | Overdose | Pandemics | Substance Abuse | Substance Abuse Disorders